Drugs / GreenGene™ F
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02027779 | Jan 2014 → Dec 2015 | hemophilia A | Green Cross Corporation | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01619046 Comparator | Mar 2013 → Jul 2015 | hemophilia A | Green Cross Corporation | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GreenGene F | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02027779 ↗ |
| Route | Intravenous | “intra-venous infusion” NCT01619046 ↗ |